These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8253557)

  • 1. Pilot trial of ribavirin for the treatment of laryngeal papillomatosis.
    McGlennen RC; Adams GL; Lewis CM; Faras AJ; Ostrow RS
    Head Neck; 1993; 15(6):504-12; discussion 512-3. PubMed ID: 8253557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
    Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
    Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis.
    Bergler WF; Götte K
    Eur Arch Otorhinolaryngol; 2000; 257(5):263-9. PubMed ID: 10923940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
    Pudszuhn A; Welzel C; Bloching M; Neumann K
    Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-viral injectable treatment (cidofovir) in laryngeal papillomatosis].
    Coulombeau B; Nusa Naiman A; Ceruse P; Froehlich P
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(5):315-20. PubMed ID: 12741293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of human papillomavirus type 6e in adult multiple laryngeal papilloma and the counterpart false cord of an interferon-treated patient.
    Ogura H; Watanabe S; Fukushima K; Baba Y; Masuda Y; Fujiwara T; Yabe Y
    Jpn J Clin Oncol; 1993 Apr; 23(2):130-3. PubMed ID: 8390585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of recurrent respiratory papillomatosis: an expert opinion.
    Gallagher TQ; Derkay CS
    Expert Opin Pharmacother; 2009 Mar; 10(4):645-55. PubMed ID: 19284366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatment for laryngeal papillomatosis.
    Kendall KA
    Curr Opin Otolaryngol Head Neck Surg; 2004 Jun; 12(3):157-9. PubMed ID: 15167022
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
    Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Brodskiĭ MIu
    Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and molecular biology studies of respiratory papillomatosis].
    Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffmann M; Rudert HH
    Laryngorhinootologie; 1998 Mar; 77(3):157-64. PubMed ID: 9577823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel treatments for recurrent respiratory papillomatosis.
    Armbruster C
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1139-48. PubMed ID: 12150707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human fibroblast interferon adjuvant to CO2 laser in the treatment of recurrent juvenile laryngeal papillomatosis: experience with 7 cases.
    Chiesa F; Donghi R; Pilotti S; Sala L; Stefanon B
    Tumori; 1989 Jun; 75(3):259-62. PubMed ID: 2549667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of photodynamic therapy on recurrent laryngeal papillomas.
    Abramson AL; Shikowitz MJ; Mullooly VM; Steinberg BM; Amella CA; Rothstein HR
    Arch Otolaryngol Head Neck Surg; 1992 Jan; 118(1):25-9. PubMed ID: 1309420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children].
    Pontes P; Weckx LL; Pignatari SS; Fujita RR; Avelino MA; Sato J
    Rev Assoc Med Bras (1992); 2009; 55(5):581-6. PubMed ID: 19918660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical 5-aminolevulinic acid photodynamic therapy for laryngeal papillomatosistosis treatment.
    Liang F; Han P; Chen R; Lin P; Luo M; Cai Q; Huang X
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():136-141. PubMed ID: 31430574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful ribavirin therapy for life-threatening laryngeal papillomatosis post liver transplantation.
    Balauff A; Sira J; Pearman K; McKiernan P; Buckels J; Kelly D
    Pediatr Transplant; 2001 Apr; 5(2):142-4. PubMed ID: 11328555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis.
    Avidano MA; Singleton GT
    Otolaryngol Head Neck Surg; 1995 Feb; 112(2):197-202. PubMed ID: 7530830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of cis-retinoic acid in recurrent respiratory papillomatosis of the larynx: a randomized pilot study.
    Bell R; Hong WK; Itri LM; McDonald G; Strong MS
    Am J Otolaryngol; 1988; 9(4):161-4. PubMed ID: 3228174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable light-dose effect on photodynamic therapy for laryngeal papillomas.
    Abramson AL; Shikowitz MJ; Mullooly VM; Steinberg BM; Hyman RB
    Arch Otolaryngol Head Neck Surg; 1994 Aug; 120(8):852-5. PubMed ID: 8049048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of conjugated linoleic acid and high oleic acid safflower oil in the treatment of children with HPV-induced laryngeal papillomatosis: a randomized, double-blinded and crossover preliminary study.
    Louw L
    Lipids Health Dis; 2012 Oct; 11():136. PubMed ID: 23061633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.